Medicis Pharmaceutical Corp. (NASDAQ: MRX) reported Q4 EPS of $0.76, $0.15 better than the analyst estimate of $0.61. Revenue for the quarter came in at $415.6 million versus the consensus estimate of $370.72 million.

For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.